Head-to-head · WeighScore
System Labs vs Trimi
By GLP-1 ScorecardUpdated
Score comparison
Trimi has the higher recorded score — 86.4/100 to 68.4/100.
Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trimi combines compounded injections and care in monthly or prepaid plans; the annual discount is substantial, but prescription-issued refund limits deserve equal attention.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | System Labs | Trimi |
|---|---|---|
| WeighScore | 68.4/100 | 86.4/100 |
| Grade | C | B |
| Site position | #101 | #9 |
| Semaglutide | No semaglutide option displayed on the inspected GLP-1 landing page; broader prescribing scope unconfirmed | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | Advertised $99 first month, then $179/mo for compounded GLP-1/GIP; confirm the exact formulation and prescription supply | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | General FAQ claims all 50 states, subject to treatment, telehealth and pharmacy limits; specific GLP-1 eligibility needs confirmation | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #101 · C
Strengths
- The landing page distinguishes its advertised $99 first month from the flat $179 ongoing monthly price
- Injection supplies, free two-day temperature-controlled shipping and no per-visit fees are advertised
- The general FAQ and terms name The Pharmacy Hub as a partner; patients still need to confirm their assigned pharmacy
- The landing page includes a compounded-treatment nonapproval disclosure and describes clinician review and ongoing support
What to consider
- The all-dose monthly package does not disclose a numeric dose range, vial concentration or volume, usable injection count or beyond-use date
- Dashboard cancellation on the landing page conflicts with email instructions and a promised future billing portal in the FAQ; no exact notice cutoff is stated
- The FAQ excludes refunds once prescriptions are ordered, while the terms describe different pharmacy-processing stages; clarify the cutoff before paying
- Patient-lab costs and the GLP-1 testing schedule remain unspecified
- The general claim of availability in all 50 states does not confirm eligibility for this particular treatment
- Named advisors and a pharmacy partner do not identify the assigned treating practice, clinician or physical compounder
- Confirm the exact formulation and available payment plans; the advertised monthly package does not settle either
Site position #9 · B
Strengths
- Separate semaglutide and tirzepatide plans include prescribed medication and care
- Monthly, quarterly, six-month and annual charges published
- BelieveRx pharmacy and Arora Health care network publicly named; individual assignment and licenses still need confirmation
- Supplies and shipping included under the published offer
What to consider
- Compounded injections only; no current branded or oral route
- Monthly and quarterly plans renew automatically; six-month and annual continuation needs a new confirmed purchase
- Ordinary orders become nonrefundable once the prescription is issued, even before shipping
- A named pharmacy partner does not independently verify the pharmacy assigned to your order
Featured provider
System Labs
System Labs scores 68.4/100 (C). Advertises a $99 introductory month and $179 ongoing compounded injection program, with The Pharmacy Hub named as a partner and prescription supply, lab cost and cancellation instructions still needing confirmation.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.